Optase Spray
Product Images NDC 72972-001

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Optase (NDC 72972-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Scope Health Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2500 2 Optase Spray Patient Information Leaflet Vs.2 (1) Page 001 (1)

Patient information leaflet for Optase Dry Eye Spray. The text explains the product's use for relieving dryness and irritation of eyes and eyelids, containing glycerin as the active ingredient. It provides instructions for use, precautions, warnings, and the full composition listing active and inactive ingredients. Manufacturer contact details for Scope Health Inc are included.*

FDA Label Image

Directions (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Dosage And Directions)

This text panel contains directions for use, instructing to spray 1-2 times the equivalent of 1 to 2 drops in the affected eye. It also includes an "Other Information" section advising to use only if the tamper seal on the top and bottom of the box is intact.*

FDA Label Image

Active (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Active)

Drug Facts panel showing active ingredients of a product with 1% glycerin. The panel likely relates to an ophthalmic drug, providing information on the active ingredient content.*

FDA Label Image

Keep Out Of Reach (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Keep Out Of Reach)

A drug facts text panel providing safety information that advises keeping the product out of reach of children and seeking medical help or contacting a poison control center immediately if swallowed. The text is from an ophthalmic spray product.*

FDA Label Image

Purpose (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Purpose)

A segment of drug label text showing a 'Purpose' section stating the product's use as an eye lubricant.*

FDA Label Image

Uses (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Uses)

This image shows a partial Drug Facts panel focusing on the uses of the medication. It indicates the product is used as a lubricant to prevent further irritation or to relieve dryness of the eye and may also be used as a protectant against further irritation. The visible text includes warnings and usage instructions relevant to an ophthalmic spray.*

FDA Label Image

Warnings (Optase Eye Spraybox Us 2019 Fda 04.04.2019 Final Warnings)

A warning and usage instruction panel for Optase (glycerin) ophthalmic spray. It includes cautions for external use only, avoiding contamination by not touching the tip of the container to surfaces, and advises against use if solution changes color or becomes cloudy. The stop use and ask doctor section lists symptoms such as eye pain, vision changes, redness or irritation, and persistent conditions lasting more than 72 hours.*

FDA Label Image

Optase Us Eye Spray Box Us 2020 Vs.3 Outer Label Pdp Only Jpg

Optase Dry Eye Spray, an ophthalmic spray product containing glycerin at 1 mg/mL strength, labeled for 300 doses in a 0.58 fl oz (17 mL) sterile bottle. The label highlights it is preservative free and designed for dry eyes, manufactured by Scope Health Inc.*

FDA Label Image

Optase Usa New Inactives Nov 2019

Drug facts panel listing inactive ingredients including Citric Acid Monohydrate, Polyoxyethylenesorbitan Monoleate, Potassium Chloride, Purified Water, Sea Buckthorn Seed Oil, Sodium Chloride, Sodium Hyaluronate, Sorbitan Monoleate, and Tromethamine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.